» Articles » PMID: 39387683

Microbiome's Role in Musculoskeletal Health Through the Gut-bone Axis Insights

Overview
Journal Gut Microbes
Date 2024 Oct 10
PMID 39387683
Authors
Affiliations
Soon will be listed here.
Abstract

The interplay between the human microbiome and the musculoskeletal system represents a burgeoning field of research with profound implications for understanding and treating musculoskeletal disorders. This review articulates the pivotal role of the microbiome in modulating bone health, highlighting the gut-bone axis as a critical nexus for potential therapeutic intervention. Through a meticulous analysis of recent clinical research, we underscore the microbiome's influence on osteoporosis, sarcopenia, osteoarthritis, and rheumatoid arthritis, delineating both the direct and indirect mechanisms by which microbiota could impact musculoskeletal integrity and function. Our investigation reveals novel insights into the microbiota's contribution to bone density regulation, hormone production, immune modulation, and nutrient absorption, laying the groundwork for innovative microbiome-based strategies in musculoskeletal disease management. Significantly, we identify the challenges hindering the translation of research into clinical practice, including the limitations of current microbial sequencing techniques and the need for standardized methodologies in microbiome studies. Furthermore, we highlight promising directions for future research, particularly in the realm of personalized medicine, where the microbiome's variability offers unique opportunities for tailored treatment approaches. This review sets a new agenda for leveraging gut microbiota in the diagnosis, prevention, and treatment of musculoskeletal conditions, marking a pivotal step toward integrating microbiome science into clinical musculoskeletal care.

Citing Articles

Microbiota-derived extracellular vesicles: current knowledge, gaps, and challenges in precision nutrition.

Marquez-Paradas E, Torrecillas-Lopez M, Barrera-Chamorro L, Del Rio-Vazquez J, Gonzalez-de la Rosa T, Montserrat-de la Paz S Front Immunol. 2025; 16:1514726.

PMID: 40051622 PMC: 11882860. DOI: 10.3389/fimmu.2025.1514726.


Fecal microbiota transplantation from postmenopausal osteoporosis human donors accelerated bone mass loss in mice.

Chen T, Wang N, Hao Y, Fu L Front Cell Infect Microbiol. 2024; 14:1488017.

PMID: 39703374 PMC: 11655470. DOI: 10.3389/fcimb.2024.1488017.

References
1.
Lv W, Lin X, Shen H, Liu H, Qiu X, Li B . Human gut microbiome impacts skeletal muscle mass via gut microbial synthesis of the short-chain fatty acid butyrate among healthy menopausal women. J Cachexia Sarcopenia Muscle. 2021; 12(6):1860-1870. PMC: 8718076. DOI: 10.1002/jcsm.12788. View

2.
Chen S, Zhang P, Duan H, Wang J, Qiu Y, Cui Z . Gut microbiota in muscular atrophy development, progression, and treatment: New therapeutic targets and opportunities. Innovation (Camb). 2023; 4(5):100479. PMC: 10394038. DOI: 10.1016/j.xinn.2023.100479. View

3.
Guss J, Taylor E, Rouse Z, Roubert S, Higgins C, Thomas C . The microbial metagenome and bone tissue composition in mice with microbiome-induced reductions in bone strength. Bone. 2019; 127:146-154. PMC: 6708759. DOI: 10.1016/j.bone.2019.06.010. View

4.
Huang Z, Stabler T, Pei F, Kraus V . Both systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammation. Osteoarthritis Cartilage. 2016; 24(10):1769-1775. PMC: 5026878. DOI: 10.1016/j.joca.2016.05.008. View

5.
Krisher T, Bar-Shavit Z . Regulation of osteoclastogenesis by integrated signals from toll-like receptors. J Cell Biochem. 2014; 115(12):2146-54. DOI: 10.1002/jcb.24891. View